USING A BUDGET IMPACT MODEL (BIM) AS A DECISION-MAKING TOOL AT THE HOSPITAL LEVEL IN FRANCE: AN EXAMPLE OF CPX-351 IN PATIENTS WITH NEWLY DIAGNOSED THERAPY-RELATED AML (T-AML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC)

Monnier, R; Bourguignon, S; Guindeuil, G; Pawlak, M

VALUE IN HEALTH, 2020; 23 (): S450